These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38748611)

  • 1. Bortezomib Inhibits Open Configurations of the 20S Proteasome.
    Henderson LW; Gautam AKS; Sharon EM; Johnson CR; Rommel NG; Anthony AJ; Russell DH; Jarrold MF; Matouschek A; Clemmer DE
    J Am Soc Mass Spectrom; 2024 Jun; 35(6):1063-1068. PubMed ID: 38748611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel 20S proteasome inhibitors by rational topology-based scaffold hopping of bortezomib.
    Xu Y; Yang X; Chen Y; Chen H; Sun H; Li W; Xie Q; Yu L; Shao L
    Bioorg Med Chem Lett; 2018 Jul; 28(12):2148-2152. PubMed ID: 29773504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design.
    Schrader J; Henneberg F; Mata RA; Tittmann K; Schneider TR; Stark H; Bourenkov G; Chari A
    Science; 2016 Aug; 353(6299):594-8. PubMed ID: 27493187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantioselective synthesis of adamantylalanine and carboranylalanine and their incorporation into the proteasome inhibitor bortezomib.
    de Bruin G; Mock ED; Hoogendoorn S; van den Nieuwendijk AM; Mazurek J; van der Marel GA; Florea BI; Overkleeft HS
    Chem Commun (Camb); 2016 Mar; 52(21):4064-7. PubMed ID: 26894389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment of human multiple myeloma cells with bortezomib and doxorubicin alters the interactome of 20S proteasomes.
    Mittenberg AG; Kuzyk VO; Shabelnikov SV; Gorbach DP; Shatrova AN; Fedorova OA; Barlev NA
    Cell Cycle; 2018; 17(14):1745-1756. PubMed ID: 30009671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Application of a Sensitive Peptide Reporter to Discover 20S Proteasome Stimulators.
    Coleman RA; Trader DJ
    ACS Comb Sci; 2018 May; 20(5):269-276. PubMed ID: 29553711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrochemical assay for 20S proteasome activity and inhibition with anti-cancer drugs.
    Henriques de Jesus CS; Chiorcea-Paquim AM; Barsan MM; Diculescu VC
    Talanta; 2019 Jul; 199():32-39. PubMed ID: 30952265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel aromatic sulfonyl naphthalene-based boronates as 20S proteasome inhibitors.
    Liu H; Wu J; Ge Y; Li A; Li J; Liu Z; Xu Y; Xu Q; Li Y
    Bioorg Med Chem; 2018 Mar; 26(5):1050-1061. PubMed ID: 29426629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of proteasome inhibitors as research tools and cancer drugs.
    Goldberg AL
    J Cell Biol; 2012 Nov; 199(4):583-8. PubMed ID: 23148232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of 20S Proteasome Configurations: Preopening the Axial Gate.
    Henderson LW; Sharon EM; Gautam AKS; Anthony AJ; Jarrold MF; Russell DH; Matouschek A; Clemmer DE
    J Phys Chem Lett; 2023 Jun; 14(21):5014-5017. PubMed ID: 37224454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Basis for the Species-Selective Binding of N,C-Capped Dipeptides to the Mycobacterium tuberculosis Proteasome.
    Hsu HC; Singh PK; Fan H; Wang R; Sukenick G; Nathan C; Lin G; Li H
    Biochemistry; 2017 Jan; 56(1):324-333. PubMed ID: 27976853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Deubiquitinase Inhibitor b-AP15 and Its Effect on Phenotype and Function of Monocyte-Derived Dendritic Cells.
    Schmidt M; Altdörfer V; Schnitte S; Fuchs AR; Kropp KN; Maurer S; Müller MR; Salih HR; Rittig SM; Grünebach F; Dörfel D
    Neoplasia; 2019 Jul; 21(7):653-664. PubMed ID: 31132676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proteostasis guardian HSF1 directs the transcription of its paralog and interactor HSF2 during proteasome dysfunction.
    Santopolo S; Riccio A; Rossi A; Santoro MG
    Cell Mol Life Sci; 2021 Feb; 78(3):1113-1129. PubMed ID: 32607595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of the boron adducts of the proteasome inhibitor bortezomib with epigallocatechin-3-gallate and related polyphenols.
    Glynn SJ; Gaffney KJ; Sainz MA; Louie SG; Petasis NA
    Org Biomol Chem; 2015 Apr; 13(13):3887-99. PubMed ID: 25669488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfiram is a slow-binding partial noncompetitive inhibitor of 20S proteasome activity.
    Hasinoff BB; Patel D
    Arch Biochem Biophys; 2017 Nov; 633():23-28. PubMed ID: 28887129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasome inhibition correlates with intracellular bortezomib concentrations but not with antiproliferative effects after bolus treatment in myeloma cell lines.
    Dettmer S; Theile D; Schäfer J; Seckinger A; Burhenne J; Weiss J
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1091-101. PubMed ID: 27422413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bortezomib Amplifies Effect on Intracellular Proteasomes by Changing Proteasome Structure.
    Pitcher DS; de Mattos-Shipley K; Tzortzis K; Auner HW; Karadimitris A; Kleijnen MF
    EBioMedicine; 2015 Jul; 2(7):642-8. PubMed ID: 26288836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional evidence for citicoline binding and modulation of 20S proteasome activity: Novel insights into its pro-proteostatic effect.
    Sbardella D; Coletta A; Tundo GR; Ahmed IMM; Bellia F; Oddone F; Manni G; Coletta M
    Biochem Pharmacol; 2020 Jul; 177():113977. PubMed ID: 32298691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cryo-EM structure of the Plasmodium falciparum 20S proteasome and its use in the fight against malaria.
    Li H; Bogyo M; da Fonseca PC
    FEBS J; 2016 Dec; 283(23):4238-4243. PubMed ID: 27286897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin allosterically inhibits the proteasome.
    Osmulski PA; Gaczynska M
    Mol Pharmacol; 2013 Jul; 84(1):104-13. PubMed ID: 23619386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.